# Semaglutide in patients with hidradenitis suppurativa and obesity.

> PubMed lists PMID 41832804 in Medicina clinica as Journal Article, with publication-date metadata of 2026-03-12 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41832804-semaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-11
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41832804-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41832804-semaglutide-v1.json
- Content SHA-256: `04f8dfa76a076b0b599502d81c302a14e57775c64d9e979f0a37af39983e5612`

## Claims and source pins

### Headline

Semaglutide in patients with hidradenitis suppurativa and obesity. ([`pubmed-observation-pmid-41832804-2026-07-11-9d1a9810bc26`](#source-pubmed-observation-pmid-41832804-2026-07-11-9d1a9810bc26))

### Summary

PubMed lists PMID 41832804 in Medicina clinica as Journal Article, with publication-date metadata of 2026-03-12 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41832804-2026-07-11-9d1a9810bc26`](#source-pubmed-observation-pmid-41832804-2026-07-11-9d1a9810bc26))

### Paragraph 1

PubMed lists PMID 41832804 in Medicina clinica as Journal Article, with publication-date metadata of 2026-03-12 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41832804-2026-07-11-9d1a9810bc26`](#source-pubmed-observation-pmid-41832804-2026-07-11-9d1a9810bc26))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41832804-2026-07-11-9d1a9810bc26`](#source-pubmed-observation-pmid-41832804-2026-07-11-9d1a9810bc26))

## Sources

<a id="source-pubmed-observation-pmid-41832804-2026-07-11-9d1a9810bc26"></a>
- **Semaglutide in patients with hidradenitis suppurativa and obesity. · retained source version 1:2026-07-11:current:9d1a9810bc26f3fdbf706a17c999acd212b6ee3e63cbbaec0c9230c1a208c9fb** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41832804/) (`pubmed-observation-pmid-41832804-2026-07-11-9d1a9810bc26`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Semaglutide in patients with hidradenitis suppurativa and obesity." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41832804-semaglutide-v1.json SHA-256: 04f8dfa76a076b0b599502d81c302a14e57775c64d9e979f0a37af39983e5612.